Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
This trial is designed to study the role of docetaxel/gemcitabine, an active and relatively
non-toxic combination in advanced NSCLC. This study will help to better define optimal
preoperative regimens for patients with resectable NSCLC. Since both of these drugs are
potent radio-sensitizers, the concurrent use with radiation therapy at these weekly doses may
produce not only radio-sensitization, but also considerable antitumor efficacy.